(Q34609924)

3 August 2017

1 reference

title

New concepts in the immunopathogenesis of multiple sclerosis (English)

1 reference

3 August 2017

0 references

3

Hans-Peter Hartung

1 reference

3 August 2017

Bernhard Hemmer

1

1 reference

3 August 2017

Juan J Archelos

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Nature Reviews Neuroscience

3 August 2017

1 reference

3 August 2017

3

1 reference

3 August 2017

4

1 reference

3 August 2017

291-301

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn784

3 August 2017

0 references

1 reference

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.

31 March 2020

1 reference

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

31 March 2020

1 reference

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

31 March 2020

1 reference

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

31 March 2020

1 reference

Genetic epidemiology of multiple sclerosis

31 March 2020

1 reference

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

31 March 2020

1 reference

Genetics of multiple sclerosis

31 March 2020

1 reference

Multiple sclerosis: genomic rewards

31 March 2020

1 reference

APOE genotype is a major predictor of long-term progression of disability in MS

31 March 2020

1 reference

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

31 March 2020

1 reference

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

31 March 2020

1 reference

Clinical viral infections and multiple sclerosis.

31 March 2020

1 reference

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

31 March 2020

1 reference

Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis

31 March 2020

1 reference

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

31 March 2020

1 reference

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

31 March 2020

1 reference

31 March 2020

1 reference

Transfer of allergic encephalomyelitis in rats by means of lymph node cells

31 March 2020

1 reference

The T lymphocyte in experimental allergic encephalomyelitis

31 March 2020

1 reference

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

31 March 2020

1 reference

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

31 March 2020

1 reference

Identification of autoantibodies associated with myelin damage in multiple sclerosis

31 March 2020

1 reference

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

31 March 2020

1 reference

MS: the return of the B cell

31 March 2020

1 reference

Immunological aspects of demyelinating diseases

31 March 2020

1 reference

The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis

31 March 2020

1 reference

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

31 March 2020

1 reference

Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone

31 March 2020

1 reference

Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?

31 March 2020

1 reference

Epitope spreading in immune-mediated diseases: implications for immunotherapy

31 March 2020

1 reference

TCR usage in human and experimental demyelinating disease

31 March 2020

1 reference

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

31 March 2020

1 reference

Genetic models for CNS inflammation

31 March 2020

1 reference

Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes

31 March 2020

1 reference

Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice

31 March 2020

1 reference

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

31 March 2020

1 reference

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Some misconceptions about understanding autoimmunity through experiments with knockouts

31 March 2020

1 reference

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

31 March 2020

1 reference

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

31 March 2020

1 reference

The adhesion molecule and cytokine profile of multiple sclerosis lesions

31 March 2020

1 reference

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

31 March 2020

1 reference

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

31 March 2020

1 reference

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

31 March 2020

1 reference

Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice

31 March 2020

1 reference

The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.

31 March 2020

1 reference

Late complications of immune deviation therapy in a nonhuman primate

31 March 2020

1 reference

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

31 March 2020

1 reference

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

31 March 2020

1 reference

The ups and downs of multiple sclerosis therapeutics

31 March 2020

1 reference

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

31 March 2020

1 reference

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

31 March 2020

1 reference

31 March 2020

Mouse hepatitis virus.

1 reference

Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells.

31 March 2020

1 reference

Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated.

31 March 2020

1 reference

Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus

31 March 2020

1 reference

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

31 March 2020

1 reference

Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis

31 March 2020

1 reference

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

31 March 2020

1 reference

Cytokines and acute neurodegeneration

31 March 2020

1 reference

Inflammatory mediators and stroke: new opportunities for novel therapeutics

31 March 2020

1 reference

Innate immunity: the missing link in neuroprotection and neurodegeneration?

31 March 2020

1 reference

Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells

31 March 2020

1 reference

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

31 March 2020

1 reference

AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS.

31 March 2020

1 reference

Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis

31 March 2020

1 reference

Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis

31 March 2020

1 reference

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

31 March 2020

1 reference

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients

31 March 2020

1 reference

The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes.

31 March 2020

1 reference

Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response

31 March 2020

1 reference

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

31 March 2020

1 reference

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

31 March 2020

1 reference

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

31 March 2020

1 reference

Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

31 March 2020

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

31 March 2020

1 reference

Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis

31 March 2020

1 reference

Glutamate excitotoxicity in a model of multiple sclerosis

31 March 2020

1 reference

The oligodendrocyte precursor cell in health and disease

31 March 2020

1 reference

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

31 March 2020

1 reference

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

31 March 2020

1 reference

Axonal transection in the lesions of multiple sclerosis

31 March 2020

1 reference

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

31 March 2020

1 reference

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

31 March 2020

1 reference

Induction of MHC class I genes in neurons

31 March 2020

1 reference

Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity

31 March 2020

1 reference

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

31 March 2020

1 reference

Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses

31 March 2020

1 reference

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

31 March 2020

1 reference

Molecular immunologic strategies to identify antigens and b-cell responses unique to multiple sclerosis

31 March 2020

1 reference

Antigen discovery in chronic human inflammatory central nervous system disease: panning phage-displayed antigen libraries identifies the targets of central nervous system-derived IgG in subacute sclerosing panencephalitis

31 March 2020

1 reference

The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries

31 March 2020

1 reference

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease

31 March 2020

1 reference

In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

31 March 2020

1 reference

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

31 March 2020

1 reference

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

31 March 2020

1 reference

Treatment of multiple sclerosis: recent trials and future perspectives

31 March 2020

1 reference

Ligand recognition by alpha beta T cell receptors

31 March 2020

1 reference

Regulation of T cell immunity by dendritic cells

31 March 2020

1 reference

The expanding universe of T-cell subsets: Th1, Th2 and more.

31 March 2020

1 reference

Clonal selection and learning in the antibody system

31 March 2020

1 reference

Plasma cells: finding new light at the end of B cell development

31 March 2020

1 reference

Immune function of microglia

31 March 2020

1 reference

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

31 March 2020

1 reference

The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications

31 March 2020

1 reference

The role of integrins in immune-mediated diseases of the nervous system

31 March 2020

1 reference

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

31 March 2020

1 reference

Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis

31 March 2020

1 reference

Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways

31 March 2020

1 reference

A meta-analysis of genomic screens in multiple sclerosis

31 March 2020

1 reference

Viral induced demyelination

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN784

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference